A detailed history of Sphera Funds Management Ltd. transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 311,572 shares of APLT stock, worth $274,183. This represents 0.49% of its overall portfolio holdings.

Number of Shares
311,572
Previous 674,268 53.79%
Holding current value
$274,183
Previous $3.15 Million 15.88%
% of portfolio
0.49%
Previous 0.46%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.35 - $8.5 $1.58 Million - $3.08 Million
-362,696 Reduced 53.79%
311,572 $2.65 Million
Q2 2024

Aug 14, 2024

BUY
$4.04 - $6.37 $223,165 - $351,872
55,239 Added 8.92%
674,268 $3.15 Million
Q1 2024

May 15, 2024

BUY
$2.25 - $7.4 $1.39 Million - $4.58 Million
619,029 New
619,029 $4.21 Million
Q2 2020

Aug 13, 2020

SELL
$29.41 - $51.23 $2 Million - $3.48 Million
-67,967 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$19.54 - $55.47 $1.33 Million - $3.77 Million
67,967 New
67,967 $2.22 Million

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $42.3M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.